Phase 3 Lower Limb Clinical Trials
3 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–3 of 3 trials
Recruiting
Phase 3
RIVAroxaban Versus Low-molecular Weight Heparin in Patients With Lower Limb Trauma Requiring Brace or CASTing
Venous ThromboembolismPulmonary EmbolismDeep Vein Thrombosis+3 more
University Hospital, Angers1,424 enrolled35 locationsNCT06195540
Not Yet Recruiting
Phase 3
The proposed study will answer the key question whether Botulinum toxin injection in the spastic (tight) lower limb muscles following stroke improves walking and the quality of life.
Lower limb spasticityPost stroke lower limb spasticityStroke+1 more
The Hospital Research Foundation80 enrolled1 locationACTRN12617001603303
Completed
Phase 3
A randomised trial of ibuprofen in addition to usual care for cellulitis of the lower limb.
Uncomplicated cellulitis of the lower limb
Dr Josh Davis46 enrolled1 locationACTRN12611000515998